DrugPipeline.net has announced the addition of “US Market Report for Continuous Glucose Monitoring 2017 - MedCore” research report to their website DrugPipeline.net

Bangalore, Karnataka -- (SBWire) -- 12/22/2016 --The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue over the forecast period and will be driven by favorable reimbursement, technological innovation and increased uptake of personal CGM among type 1 diabetics and insulin-dependent type 2 diabetics. Professional CGM is typically used in retrospective sessions initiated by physicians, during which a patient wears a CGM sensor for several days to a week, but is 'blinded' to the real-time CGM data and must adhere to frequent self-monitoring of blood glucose (SMBG) using traditional blood glucose meters.

Additionally, the patient must maintain a record of their daily dietary intake and activity during the time that the sensor is worn. At the end of the session, the patient returns to their physician to remove the sensor and retrospectively analyze the glucose data that was collected. The 'blinded' aspect of professional CGM allows physicians to more easily assess their patient's behavior because their actions are not influenced by 'real-time' glucose data, as is the case with personal CGM products.

Spanning over 74 pages "US Market Report for Continuous Glucose Monitoring 2017 - MedCore" report covers Executive Summary, Competitive Analysis, Research Methodology, Disease Overview, Continuous Glucose Monitoring Market. The report covered companies are - Sanofi, Novo Nordisk, Eli Lilly, Medtronic, Johnson & Johnson, Becton Dickinson, Abbott, Roche, DexCom, Ascensia, Insulet, Trividia Health, Tandem, Nova Biomedical, Valeritas

For more information Visit at: http://www.drugpipeline.net/idata-research/us-market-report-continuous-glucose-monitoring-2017-medcore

About DrugPipeline.net
DrugPipeline.net is a market research reports distribution platform which hosts research reports from all leading global market research firms related to pharma industry. It also assist decision makers locate the right market research solution from a single place.